Skip to content

The value of Platelet-Rich Plasma in chronic midportion Achilles tendinopathy: a double-blind randomised clinical trial

The value of Platelet-Rich Plasma in chronic midportion Achilles tendinopathy: a double-blind randomised clinical trial - PRP injection in Achilles tendinopathy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON31856
Enrollment
54
Registered
2008-07-04
Start date
2008-08-28
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

achillodynia tendon overuse injury

Interventions

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1.Pain on palpation 2-7 cm proximal from the tendon insertion ("midportion") 2.Symptoms > 2 months 3.Age 18-70 years

Exclusion criteria

Exclusion criteria: 1.Insertional Achilles tendinopathy 2.Achilles tendon rupture 3.Tenosynovitis of the plantar flexors 4.Sural nerve pathology 5.(sub)luxation mm. Peroneï 6.Suspicion of a systemic disease:spondylarthropathy, gout, hyperlipidemia, Rheumatoid Arthritis en sarcoidosis 7.Inability to perform a heavy load exercise programme 8.Previous performance of heavy load eccentric exercise programme according to Alfredson et al. (12 weeks) 9.Previous injection with PRP for the same injury 10.Unwillingness of the patient to participate in one of the two treatment groups 11.presence of a pregnancy 12.Prescribed drugs with a putative effect on symptoms and tendon healing, for example quinolone antibiotics

Design outcomes

Primary

MeasureTime frame
Primary outcome measurement: VISA-A score, a validated instrument to detect the severity of symptoms in patients with Achilles tendinopathy.

Secondary

MeasureTime frame
As secondary outcome measurements subjective patient satisfaction and return to sports will be rated. For the evaluation of tendon repair, Ultrasonographic Tissue Characterization (UTC) and Power Doppler ultrasound (PDU) will be performed. UTC was developed, that provides quantitative information on tendon fiber alignment and the related ultra-structural integrity of the tendon tissue through a non-invasive approach.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)